Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

IBBQ vs BIB overlap: 51% of top holdings shared

Bottom line

How much do IBBQ and BIB overlap?

51% of their top holdings overlap by weight. 15 securities appear in both funds' top 25, making up 48.4% of IBBQ's assets and 30.5% of BIB's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

IBBQBIB
Weight overlap (top 25)51%
Shared holdings15
Weight in shared holdings48.4%30.5%
Total positions261267
Expense ratio0.19%0.95%
Holdings as ofMay 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Holdings IBBQ and BIB have in common

Holding% of IBBQ% of BIBOverlap
Gilead Sciences, Inc.7.39%4.66%4.66%
Vertex Pharmaceuticals Inc.7.38%4.65%4.65%
Amgen Inc.7.10%4.48%4.48%
Regeneron Pharmaceuticals, Inc.5.08%3.21%3.21%
Alnylam Pharmaceuticals, Inc.3.19%2.01%2.01%
Revolution Medicines, Inc.2.48%1.57%1.57%
Biogen Inc.2.29%1.44%1.44%
Illumina, Inc.1.98%1.25%1.25%
United Therapeutics Corp.1.94%1.22%1.22%
argenx SE1.89%1.19%1.19%
Insmed Inc.1.83%1.16%1.16%
Incyte Corp.1.53%0.97%0.97%
Viatris Inc.1.49%0.94%0.94%
Moderna, Inc.1.48%0.94%0.94%
Guardant Health, Inc.1.35%0.85%0.85%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in IBBQ

  1. Invesco Private Prime Fund — 14.20%
  2. Invesco Private Government Fund — 5.48%
  3. Royalty Pharma PLC — 1.90%
  4. Roivant Sciences Ltd. — 1.71%
  5. Neurocrine Biosciences, Inc. — 1.26%
  6. Jazz Pharmaceuticals PLC — 1.16%
  7. Ascendis Pharma A/S — 1.10%
  8. Summit Therapeutics Inc. — 1.08%
  9. Exelixis, Inc. — 1.04%
  10. BridgeBio Pharma, Inc. — 1.02%

Only in BIB

  1. N/a — 7.35%
  2. ProShares GENIUS Money Market ETF — 6.80%
  3. N/a — 3.94%
  4. N/a — 3.26%
  5. N/a — 2.62%
  6. Repurchase Agreement — 1.28%
  7. Royalty Pharma plc — 1.20%
  8. N/a — 1.18%
  9. Roivant Sciences Ltd. — 1.08%
  10. Invesco Govt And Agcy Lex — 0.81%

Asset mix

Asset typeIBBQBIB
Stocks99.9%63.0%
Cash & short-term funds19.7%0.8%
Equity derivatives—16.0%
Other—6.8%
Repurchase agreements—3.1%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Country mix

CountryIBBQBIB
US103.8%79.8%
GB2.7%1.7%
NL2.5%1.6%
IE1.9%1.2%
BM1.7%1.1%
FR1.5%1.0%
DK1.2%0.8%
CH1.2%0.8%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do IBBQ and BIB overlap?
About 51% by weight. 15 securities appear in both funds' top 25 holdings; they make up 48.4% of IBBQ's assets and 30.5% of BIB's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do IBBQ and BIB have in common?
The largest shared holdings are Gilead Sciences, Inc., Vertex Pharmaceuticals Inc., Amgen Inc., Regeneron Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc..
Should I own both IBBQ and BIB?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, IBBQ or BIB?
BIB is broader, with 267 positions versus 261 for IBBQ. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.